Table: Oncolys Biopharma - 6-MTH parent results

Oncolys Biopharma

05/08/2022 07:00

Aug 5 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Jun 30, 2022        Jun 30, 2021      Dec 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            426 mln             193 mln            1.00      
                                     (+41.8 pct)                    
  Operating     loss 658 mln        loss 633 mln        loss 1.60   
  Recurring     loss 590 mln        loss 649 mln        loss 1.60   
  Net           loss 570 mln        loss 650 mln        loss 1.60   
  EPS          loss 32.92 yen      loss 39.45 yen    loss 94.59 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T